135 related articles for article (PubMed ID: 34784305)
61. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
[TBL] [Abstract][Full Text] [Related]
62. Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer.
Zhang Y; Fu F; Wen Z; Deng L; Wang S; Li Y; Chen H
Ann Thorac Surg; 2020 Apr; 109(4):1061-1068. PubMed ID: 31863756
[TBL] [Abstract][Full Text] [Related]
63. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
[TBL] [Abstract][Full Text] [Related]
64. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
[TBL] [Abstract][Full Text] [Related]
65. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
66. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
[TBL] [Abstract][Full Text] [Related]
67. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study.
Sato T; Shimada Y; Mimae T; Tsutani Y; Miyata Y; Ito H; Nakayama H; Okada M; Ikeda N
Lung Cancer; 2021 Aug; 158():9-14. PubMed ID: 34090182
[TBL] [Abstract][Full Text] [Related]
68. Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.
Liu T; Liu H; Li Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):49-53. PubMed ID: 24787666
[TBL] [Abstract][Full Text] [Related]
69. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy.
Dehing-Oberije C; De Ruysscher D; van der Weide H; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Simons J; Teule J; Rahmy A; Thimister P; Steck H; Lambin P
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1039-44. PubMed ID: 17889446
[TBL] [Abstract][Full Text] [Related]
70. Solid part size is an important predictor of nodal metastasis in lung cancer with a subsolid tumor.
Cho JY; Leem CS; Kim Y; Kim ES; Lee SH; Lee YJ; Park JS; Cho YJ; Lee JH; Lee CT; Yoon HI
BMC Pulm Med; 2018 Sep; 18(1):151. PubMed ID: 30200917
[TBL] [Abstract][Full Text] [Related]
71. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
[TBL] [Abstract][Full Text] [Related]
72. SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
J Cell Biochem; 2019 Sep; 120(9):15422-15428. PubMed ID: 31050364
[TBL] [Abstract][Full Text] [Related]
73. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
74. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
[TBL] [Abstract][Full Text] [Related]
75. [Meta-analysis of relationship between lymph node micrometastasis and prognosis in stage I non-small cell lung cancer patients].
Zheng Z; Pan TC; Li J; Chen T; Song DW; Yi J
Ai Zheng; 2004 Feb; 23(2):185-8. PubMed ID: 14960241
[TBL] [Abstract][Full Text] [Related]
76. Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients.
Xie F; Zhang Y; Mao X; Zheng X; Han-Zhang H; Ye J; Zhao R; Zhang X; Sun J
Lung Cancer; 2018 Jul; 121():54-60. PubMed ID: 29858028
[TBL] [Abstract][Full Text] [Related]
77. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
[TBL] [Abstract][Full Text] [Related]
78. Minimizing residual occult nodal metastasis in NSCLC: recent advances, current status and controversies.
Dezube AR; Jaklitsch MT
Expert Rev Anticancer Ther; 2020 Feb; 20(2):117-130. PubMed ID: 32003589
[No Abstract] [Full Text] [Related]
79. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
Li J; Tu Y; Jiang L; Xu H; Zhang S
Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
[TBL] [Abstract][Full Text] [Related]
80. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis.
Yu X; Li Y; Shi C; Han B
Thorac Cancer; 2018 Jan; 9(1):3-9. PubMed ID: 29034994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
